ABSTRACT
Introduction: The aim of this study was to explore the clinical effect of transurethral columnar balloon dilation of the prostate (TUCBDP), in the treatment of benign prostatic hyperplasia in men over the age of 60 years old. Methods: This was a retrospective multi-center study follow-up of patients with benign prostatic hyperplasia (BPH) who underwent TUCBDP. The international prostate symptom score (IPSS), quality of life score (QoL), residual urine volume (PVR), andmaximum urine flow rate (Qmax) were evaluated one and six months after the procedure. Results: All 68 patients had the operation from January 2019 to December 2021. Their postoperative IPSS, QoL, PVR, andQmax of the patients significantly improved, in comparison to before procedure (p < 0.05). The improvement rate of IPSS andQoL in the small volume BPH group was significantly higher than that in the non-small volume BPH group (p < 0.05), but had little effect on the improvement rate of PVR and Qmax. Conclusions: TUCBDP can significantly improve IPSS, QoL, PVR, and Qmax in elderly men with BPH up to six months after theprocedure, with the advantages of shorter operation time and less blood loss. The postoperative improvement effect of patientswith small volume BPH was more obvious than that of patients with non-small volume BPH (AU)
Subject(s)
Humans , Male , Middle Aged , Prostatic Hyperplasia/therapy , Dilatation/methods , Retrospective Studies , Follow-Up StudiesABSTRACT
INTRODUCTION: The aim of this study was to explore the clinical effect of transurethral columnar balloon dilation of the prostate (TUCBDP), in the treatment of benign prostatic hyperplasia in men over the age of 60 years old. METHODS: This was a retrospective multi-center study follow-up of patients with benign prostatic hyperplasia (BPH) who underwent TUCBDP. The international prostate symptom score (IPSS), quality of life score (QoL), residual urine volume (PVR), and maximum urine flow rate (Qmax) were evaluated one and six months after the procedure. RESULTS: All 68 patients had the operation from January 2019 to December 2021. Their postoperative IPSS, QoL, PVR, and Qmax of the patients significantly improved, in comparison to before procedure (p < 0.05). The improvement rate of IPSS and QoL in the small volume BPH group was significantly higher than that in the non-small volume BPH group (p < 0.05), but had little effect on the improvement rate of PVR and Qmax. CONCLUSIONS: TUCBDP can significantly improve IPSS, QoL, PVR, and Qmax in elderly men with BPH up to six months after the procedure, with the advantages of shorter operation time and less blood loss. The postoperative improvement effect of patients with small volume BPH was more obvious than that of patients with non-small volume BPH.
